Antagonists of the vanilloid receptor subtype 1 (VR1) and uses thereof

Details for Australian Patent Application No. 2006243987 (hide)

Owner Abbott Laboratories

Inventors Koenig, John; Lee, Chih-Hung; Hsu, Margaret Chi-Ping; Gomtsyan, Arthur; Fernando, Dilini; Perner, Richard

Agent Spruson & Ferguson

Pub. Number AU-B-2006243987

PCT Pub. Number WO2006/122250

Priority 60/679,708 11.05.05 US

Filing date 10 May 2006

Wipo publication date 16 November 2006

Acceptance publication date 24 November 2011

International Classifications

C07D 263/48 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

A61K 31/421 (2006.01) - 1,3-Oxazoles, e.g. pemoline, trimethadione

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

13 December 2007 PCT application entered the National Phase

  PCT publication WO2006/122250 Priority application(s): WO2006/122250

24 January 2008 Corrigenda

  PCT applications that have entered the National Phase - Name Index Under the name Abbott Laboratories, Application No. 2006243987, under INID (54), correct the title to read Antagonists of the vanilloid receptor subtype 1 (VR1) and uses thereof

24 November 2011 Application Accepted

  Published as AU-B-2006243987

22 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006243994-Nebulization of monoclonal antibodies for treating pulmonary diseases

2006243986-Use of plasmin for preventing of reducing the rate of the progression of nonproliferative diabetic retinopathy and the treatment of other ocular conditions